Skip to main content
OpenTrials
Completed

NCT Number: NCT03292107

Study on Management Thrombosis in Greek Cancer Patients

Study on Management Thrombosis in Greek cancer patients

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hellenic Society of Medical Oncology

Athens, 11475, Greece

About this study

The approach that Medical Oncologists encounter the prospect of a coagulation event occurrence in cancer patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients diagnosed with histologically confirmed solid tumors that are under anticoagulation therapy, during the study timeline.
  • Age ≥ 18 years
  • Signed informed consent

Exclusion criteria

  • Initiation of anticoagulation therapy before the initiation of the study in 2016
  • Age <18 years
  • No signed informed consent

Treatment and study plan

Primary outcomes

  1. The clinical practice for patients under anticoagulation regime

    Time frame: 1 YEAR

    Documentation of the clinical practice for patients under anticoagulation regime, for prophylaxis or treatment, in patients with solid tumors, for one year following the protocol initiation date, including high-risk patients as defined in the protocol.

Sponsors and collaborators

Lead sponsor

Hellenic Society of Medical Oncology

Other

Registry information

Official study title

Study on Management Thrombosis in Greek Cancer Patients (GMaT - Greek Management Thrombosis)

Acronym: GMaT

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Sep 25, 2017
Registry last updated
Apr 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.